These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 13502940)
21. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
22. [Attempts at differentiation of mycobacteria sensitive and resistant to INH by the aid of quantitative and qualitative tests of peroxidase activity. Discussion of technical problems]. ANDREJEW A; GERNEZ-RIEUX C; TACQUET A Ann Inst Pasteur (Paris); 1960 Dec; 99():821-38. PubMed ID: 13683419 [No Abstract] [Full Text] [Related]
23. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function. Kapetanaki SM; Chouchane S; Yu S; Zhao X; Magliozzo RS; Schelvis JP Biochemistry; 2005 Jan; 44(1):243-52. PubMed ID: 15628865 [TBL] [Abstract][Full Text] [Related]
24. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients. Abbadi S; El Hadidy G; Gomaa N; Cooksey R Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles. Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384 [TBL] [Abstract][Full Text] [Related]
26. [Catalase activity, virulence and isoniazid sensitivity of Mycobacteria]. BONICKE R Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 117(1):171-9. PubMed ID: 13522531 [No Abstract] [Full Text] [Related]
27. [Catalase activity and virulence of Mycobacterium tuberculosis resistant to isonicotinic acid hydrazide]. STRUPCZEWSKA-JANUSZOWA H Gruzlica (1926); 1959 Feb; 27(2):117-24. PubMed ID: 13664103 [No Abstract] [Full Text] [Related]
28. [Detection of drug-resistant Mycobacterium tuberculosis isolates using DNA microarray]. Yoshikawa Y; Ichihara T; Suzuki Y Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2003; 14(1):45-50. PubMed ID: 14984307 [TBL] [Abstract][Full Text] [Related]
29. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T. Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090 [TBL] [Abstract][Full Text] [Related]
30. Investigation of catalase and peroxidase activity of Lowenstein cultures. Relationship between enzyme activity, isoniazid susceptibility and guinea-pig tests. OSCARSSON PN Acta Tuberc Scand; 1961; 40():51-64. PubMed ID: 13731394 [No Abstract] [Full Text] [Related]
31. Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates. Negi SS; Anand R; Pasha ST; Gupta S; Basir SF; Khare S; Lal S Indian J Exp Biol; 2006 Jul; 44(7):547-53. PubMed ID: 16872043 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase. Zhao X; Yu S; Magliozzo RS Biochemistry; 2007 Mar; 46(11):3161-70. PubMed ID: 17309235 [TBL] [Abstract][Full Text] [Related]
33. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB. Ghiladi RA; Cabelli DE; Ortiz de Montellano PR J Am Chem Soc; 2004 Apr; 126(15):4772-3. PubMed ID: 15080669 [TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Nusrath Unissa A; Selvakumar N; Narayanan S; Narayanan PR Int J Antimicrob Agents; 2008 Jan; 31(1):71-5. PubMed ID: 18006278 [TBL] [Abstract][Full Text] [Related]
35. [Catalase reaction in detection of strains of tubercle bacilli resistant to isoniazid]. MARSEILLE A Ned Tijdschr Geneeskd; 1955 Feb; 99(9):619-21. PubMed ID: 14370293 [No Abstract] [Full Text] [Related]
36. [DETERMINATION OF THE CATALASE AND PEROXIDASE ACTIVITY OF TUBERCULOUS STRAINS ISOLATED FROM DIAGNOSTIC MATERIAL BY THE SLIDE AND TEST TUBE METHOD]. JANOWIEC M; ZWOLSKA Z Gruzlica (1926); 1963 Aug; 31():865-73. PubMed ID: 14055228 [No Abstract] [Full Text] [Related]
37. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855 [TBL] [Abstract][Full Text] [Related]
38. [Qualitative studies on catalases of Mycobacterium tuberculosis]. POLSTER M Lek List; 1953 Dec; 8(23):556-7. PubMed ID: 13131914 [No Abstract] [Full Text] [Related]
39. [Studies on the peroxidase of Mycobacterium tuberculosis]. TOMODA T Kekkaku; 1958 Oct; 33(10):674-8; English abstract 705. PubMed ID: 13611841 [No Abstract] [Full Text] [Related]
40. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis. Sriram D; Yogeeswari P; Yelamanchili Priya D Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]